Trademark: 97042423
Status Date
Tuesday, March 19, 2024
Filing Date
Thursday, September 23, 2021
Published for Opposition
Tuesday, June 27, 2023
9 Downloadable computer software for conducting research for ultra-high dose radiotherapy, treatment planning and patient monitoring; Downloadable computer software for evaluating treatment results for radiotherapy; Downloadable computer software for research about treatment plans for radiotherapy; Downloadable computer software for managing patient medical and treatment information; Downloadable computer software for creating searchable databases of information and data for use with medical research
10 Medical linear accelerators used in radiotherapy and computer software embedded therein for use in the field of radiotherapy, sold as a unit; Medical apparatus, namely, medical device for use in patient positioning and immobilization during radiotherapy treatment, patient imaging, and diagnosis using scanning devices; Medical apparatus for locating and targeting cancer volumes in a body for use in radiation treatments; Medical apparatus, namely, medical device for maintaining patient positioning between and during treatment, imaging, diagnosis and simulation treatment in the field of radiation therapy; Radiation beam collimation apparatus for conformal beam radiotherapy; all of the foregoing goods limited to the radiation oncology field; Medical charged particle accelerators used in radiotherapy and computer software embedded therein for use in the field of radiotherapy, sold as a unit; Medical radiation delivery devices, namely, radiation therapy device; Ultra-high dose rate radiotherapy medical apparatus used for diagnostic, therapeutic and radiographic purposes and computer software embedded therein, sold as a unit, for use in the fields of radiotherapy and radiosurgery; Medical charged particle accelerators used in radiotherapy and radiosurgery and computer software embedded therein, sold as a unit, for use in the fields of radiotherapy and radiosurgery; Medical imaging apparatus for ultra-high dose rate radiotherapy treatment planning; Medical apparatus in the nature of devices for positioning patients, immobilizing limbs, and controlling patient motion during ultra-high dose rate radiotherapy treatment
42 Providing online non-downloadable software for researching medical information, patient data, and patient treatment information; Providing online non-downloadable software for research to assist patients and medical professionals in formulating medical diagnoses and developing, adapting and facilitating medical treatment plans; Providing online non-downloadable software for research regarding ultra-high dose oncology treatment and patient care data management and analytics; Providing online non-downloadable software for controlling radiotherapy medical apparatus for use with oncology treatment; Consulting services in the field of hosting computer software applications; Providing technical support services, namely, troubleshooting of computer hardware and software problems and providing solutions to the problems; Providing online non-downloadable software for management and analysis of ultra-high dose oncology treatment and patient care data; Providing online non-downloadable software for use with oncology treatment devices and for creating and facilitating ultra-high dose oncology treatment plans
Mar 20, 2024
Notice Of Acceptance Of Statement Of Use E-Mailed
Mar 19, 2024
Allowed Principal Register - Sou Accepted
Mar 19, 2024
Statement Of Use Processing Complete
Feb 26, 2024
Use Amendment Filed
Mar 18, 2024
Case Assigned To Intent To Use Paralegal
Feb 26, 2024
Teas Statement Of Use Received
Feb 13, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 12, 2024
Sou Extension 1 Granted
Feb 12, 2024
Sou Extension 1 Filed
Feb 12, 2024
Sou Teas Extension Received
Aug 22, 2023
Noa E-Mailed - Sou Required From Applicant
Jun 27, 2023
Official Gazette Publication Confirmation E-Mailed
Jun 27, 2023
Published For Opposition
Jun 7, 2023
Notification Of Notice Of Publication E-Mailed
May 25, 2023
Approved For Pub - Principal Register
May 25, 2023
Examiner's Amendment Entered
May 25, 2023
Notification Of Examiners Amendment E-Mailed
May 25, 2023
Examiners Amendment E-Mailed
May 25, 2023
Examiners Amendment -Written
Nov 28, 2022
Notification Of Final Refusal Emailed
Nov 28, 2022
Final Refusal E-Mailed
Nov 28, 2022
Final Refusal Written
Oct 29, 2022
Teas/Email Correspondence Entered
Oct 28, 2022
Correspondence Received In Law Office
Oct 28, 2022
Teas Response To Office Action Received
May 31, 2022
Notification Of Non-Final Action E-Mailed
May 31, 2022
Non-Final Action E-Mailed
May 31, 2022
Non-Final Action Written
May 23, 2022
Assigned To Examiner
Oct 25, 2021
New Application Office Supplied Data Entered
Sep 27, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
